Genotype-phenotype correlations in pediatric patients with myotonic dystrophy type 1.

Age of onset CTG repeat Genotype Myotonic dystrophy type 1 Phenotype

Journal

Korean journal of pediatrics
ISSN: 1738-1061
Titre abrégé: Korean J Pediatr
Pays: Korea (South)
ID NLM: 101215374

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 28 08 2018
accepted: 20 09 2018
pubmed: 12 10 2018
medline: 12 10 2018
entrez: 12 10 2018
Statut: ppublish

Résumé

Myotonic dystrophy, also known as dystrophia myotonica (DM), is an autosomal dominant disorder with 2 genetically distinct forms. DM type 1 (DM1) is the more common form and is caused by abnormal expansion of cytosine/thymine/guanine (CTG) repeats in the DM protein kinase (DMPK ) gene. Our study aimed to determine whether the age of onset is correlated with CTG repeat length in a population of pediatric patients with DM1. We retrospectively identified 30 pediatric patients with DM1 that underwent DMPK testing, of which the clinical data of 17 was sufficient. The cohort was divided into 2 subgroups based on the clinical phenotype (congenital-onset vs. late-onset) and number of CTG repeats (<1,000 vs. ≥1,000). We found no significant difference between the age of onset and CTG repeat length in our pediatric patient population. Based on clinical subgrouping, we found that the congenital-onset subgroup was statistically different with respect to several variables, including prematurity, rate of admission to neonatal intensive care unit, need for respiratory support at birth, hypotonia, dysphagia, ventilator dependence, and functional status on last visit, compared to the late-onset subgroup. Based on genetic subgrouping, we found a single variable (poor feeding in neonate) that was significantly different in the large CTG subgroup than that in the small CTG subgroup. Clinical variables exhibiting statistically significant differences between the subgroups should be focused on prognosis and designing tailored management approaches for the patients; our findings will contribute to achieve this important goal for treating patients with DM1.

Identifiants

pubmed: 30304901
pii: kjp.2018.06919
doi: 10.3345/kjp.2018.06919
pmc: PMC6382962
doi:

Types de publication

Journal Article

Langues

eng

Pagination

55-61

Références

Hum Mutat. 2002 Feb;19(2):131-9
pubmed: 11793472
Cell. 1992 Feb 21;68(4):799-808
pubmed: 1310900
Science. 1992 Mar 6;255(5049):1253-5
pubmed: 1546325
Intern Med. 2005 Oct;44(10):1027-32
pubmed: 16293911
Neurology. 2006 Apr 25;66(8):1248-50
pubmed: 16636244
Korean J Lab Med. 2008 Dec;28(6):483-92
pubmed: 19127114
Am J Med Genet A. 2009 Jul;149A(7):1365-74
pubmed: 19514047
B-ENT. 2015;11(4):249-56
pubmed: 26891535
Rev Neurol (Paris). 2016 Oct;172(10):572-580
pubmed: 27665240
Curr Treat Options Neurol. 2016 Dec;18(12):52
pubmed: 27826760
Muscle Nerve. 2017 Oct;56(4):816-818
pubmed: 28181267
J Neurol Neurosurg Psychiatry. 1970 Jun;33(3):279-93
pubmed: 5431719
Arch Neurol. 1993 Nov;50(11):1173-9
pubmed: 8215976
Am J Hum Genet. 1993 Jun;52(6):1164-74
pubmed: 8503448
J Med Genet. 1999 Jan;36(1):59-61
pubmed: 9950368

Auteurs

Hyeong Jung Kim (HJ)

Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.

Ji-Hoon Na (JH)

Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.

Young-Mock Lee (YM)

Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.

Classifications MeSH